Lux Research, the world's leading research and advisory firm for nanotechnology, today announced new speakers and features at the second annual Lux Executive Summit: Commercializing Nanotechnology, to be held on October 16-17, 2006 at the Charles Hotel in Cambridge, Massachusetts.
The Lux Executive Summit will feature exclusive presentations from Lux Research's world-renowned analyst team in addition to top executives at leading firms active in nanotechnology such as IBM, 3M, Bayer, Medtronic, and DuPont. Leaders from Global 1,000 corporations slated to present their strategies to commercialize nanotechnology include Motorola's VP of Embedded Systems Vida Ilderim; IBM's Director of Physical Sciences Tom Theis; Bayer's VP of Future Business Robert Kumpf; DuPont's Global Director of Corporate Regulatory Affairs Terry Medley; and Air Products' CTO Miles Drake. Top executives recently added to the speaking roster include Saied Tehrani, Director of MRAM Technology at Freescale Semiconductor; Thomas Sawitowski, Manager of Nanotechnology at Altana Chemie; Jake Reder, New Business Development Project Leader at Cabot Corporation; and Larry Carlson, VP of R&D at Eastman Sports.
The Lux Executive Summit will also host dozens of CEOs from the most promising companies in nanotechnology and the physical sciences. Participating CEOs hail from companies like Nucryst Pharmaceuticals, Nanogram, NanoTerra, Lumera, Altair Nano, Starpharma, Integran, Kereos, AION Diagnostics, Advanced Nanotechnology, Sirtris Pharmaceuticals, NanoOpto, and NanoBioMagnetics. Start-up CEOs recently added to the speaking roster include Don Young of Aspen Aerogels; David Vieau of A123Systems; Joe Carr of Semprius; Kevin Matthews of Oxonica; William Moffitt of Nanosphere; and Leonard Dolhert of Primet Precision Materials.
"Commercialization of advanced technologies requires corporations and start-ups to work hand-in-hand," said Lux Research CEO Peter Hebert. "The Lux Executive Summit's highly selective attendee list ensures that executives find the decision-makers they want to meet - and proprietary content from the Lux Research analyst team sets the stage for the deals they want to sign."
2006 Lux Executive Summit sponsors include BOC Group, Foley & Lardner LLP, PowerShares Capital Management, Lumera, NanoTerra, Nucryst Pharmaceuticals, Altair Nanotechnologies, Gradient Corporation, Starpharma, Telomolecular, The Livingston Group/Axiom Capital Management, and Beecher Carlson. For the 2006 Lux Executive Summit agenda, early registration and additional event details, please visit www.luxexecutivesummit.com. For more information on speaker and sponsorship opportunities, contact Lux Research Vice President Rob Burns at email@example.com.
The Lux Executive Summit is the only event designed to provide corporate executives and investment managers with the knowledge and insights required to create a visionary nanotechnology strategy. The event is grounded by the proprietary data and analysis from Lux Research's world-renowned analyst team, joined onstage by more than 50 speakers from large corporations, innovative start-ups, forward-thinking investment management firms, and the public sector. Capacity is limited at this premier event; additional details are available online at http://www.luxexecutivesummit.com.